Posted 21 February 2021 AM
Eisai has registered a new formulation of its PBS-listed seizure treatment Fycompa. The new version of the medication can be taken via oral suspension, rather than tablets.
It joined HIV specialist ViiV's Vocabris tablets as an addition to the ARTG during the week. This medicine is indicated for short term use with Janssen's Edurant oral lead in to assess tolerability of cabotegravir prior to administration of cabotegravir prolonged-release suspension for injection plus rilpivirine prolonged-release suspension for injection.